Evaluating new treatments for osteoporosis after denosumab therapy in Japanese patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the efficacy and safety of different anti-resorption drugs in Japanese patients with osteoporosis who have previously undergone two years of denosumab therapy. Participants will be divided into three groups, receiving either SERM and eldecalcitol, bisphosphonates and eldecalcitol, or solely eldecalcitol for an additional 24 months. The study aims to assess both the effectiveness of these treatments and any adverse events that may arise during the treatment period.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* osteoporosis patients

Exclusion Criteria:

* not osteoporosis patients who are allergic to the drugs, refused to do this research, or who are pregnant

Where it's running

• Yukio Nakamura
  Matsumoto, Nagano, Japan Recruiting

Study contacts

• Study coordinator: Yukio Nakamura
• Email: yxn14@aol.jp
• Phone: +81263372576

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ibandronate vs. Zoledronic Acid After Denosumab: Is Either Equal for Postmenopausal Osteoporosis?

  In postmenopausal osteoporosis, this study tests whether intravenous ibandronate given after stopping denosumab works as well as zoledronic acid over a year.

  Recruiting Phase 4 National Taiwan University Hospital · Taipei · NCT07406685

• Romosozumab and denosumab alone or together for postmenopausal osteoporosis

  This 6-month pilot tests whether cyclic romosozumab combined with denosumab improves bone density more than denosumab alone in postmenopausal women with osteoporosis.

  Recruiting Phase 4 National Taiwan University Hospital · Douliu, Taiwan · NCT07283887

• Denosumab effects on muscle strength and insulin sensitivity

  This trial will test whether denosumab improves muscle strength and insulin sensitivity in postmenopausal women with osteoporosis and type 2 diabetes who are taking metformin.

  Recruiting Phase 4 Aarhus University Hospital · Aarhus · NCT07271771

• Comparing two treatment regimens for osteoporosis in postmenopausal women

  This study is testing two different treatment plans for osteoporosis in postmenopausal women to see which one helps improve bone strength and reduce the risk of fractures better.

  Recruiting Phase 4 National Taiwan University Hospital · Taipei · NCT06938152

• Preventing bone loss in critically ill adults using medications

  This study is testing if two medications can help prevent bone loss in critically ill adults over 50 who have been in the ICU for more than a day.

  Recruiting at 20 sites Phase 2 Australian and New Zealand Intensive Care Research Centre · Sydney, New South Wales and 21 other locations · NCT04608630

• Role of LH and hCG in adults being evaluated for endocrine disorders

  This study looks at whether levels of luteinizing hormone (LH) and hCG in adults undergoing endocrine evaluation relate to their disease presence and outcomes.

  Recruiting Copenhagen University Hospital at Herlev · Herlev · NCT07824102

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.